What is the recommended duration of amoxicillin therapy for uncomplicated infections such as acute otitis media, sinusitis, bronchitis, or uncomplicated skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Duration of Amoxicillin Therapy

For uncomplicated infections in children 2 years and older and adults, prescribe amoxicillin for 5 days, not the traditional 10 days.

Evidence-Based Duration by Infection Type

Acute Otitis Media (AOM)

  • 5-7 days for children ≥2 years with uncomplicated AOM 1
  • Recent multicenter data (7,528 children) showed 5-day courses had equivalent treatment failure rates (0.44%) compared to 7-day courses (0.61%), with no significant difference 2
  • The FDA label states treatment should continue for 48-72 hours beyond symptom resolution 3
  • Exception: Children with AOM in the preceding month may benefit from 10-day therapy due to higher risk of resistant organisms 4

Acute Sinusitis

  • 5 days is appropriate for uncomplicated acute bacterial sinusitis 1
  • Meta-analysis of 4,430 patients showed no difference in clinical success between 3-7 days versus 6-10 days, with fewer adverse events in the 5-day group 5

Acute Bronchitis (with COPD exacerbation)

  • 5 days when bacterial infection is clinically evident (increased sputum purulence plus increased dyspnea and/or sputum volume) 1
  • Meta-analysis of 10,698 patients showed no difference in clinical improvement between short-course (mean 4.9 days) versus long treatment (mean 8.3 days) 1

Uncomplicated Skin Infections (Cellulitis)

  • 5-6 days for nonpurulent cellulitis with streptococcal coverage 1
  • Applies particularly to patients who can self-monitor with close primary care follow-up

Critical Caveats

Streptococcus pyogenes infections require special consideration:

  • The FDA label mandates at least 10 days of treatment for any S. pyogenes infection to prevent acute rheumatic fever 3
  • This applies to streptococcal pharyngitis/tonsillitis
  • Standard-dose penicillin given three times daily should be continued for 10 days 5
  • Alternative: High-dose penicillin four times daily for 5 days or short-course cephalosporins (4-6 days) may be equivalent 5

Key Clinical Principles

The 2021 American College of Physicians guidelines emphasize that prolonged antibiotic use beyond symptom resolution does not reduce resistance—it increases it through selection pressure 1. Despite 75% of clinicians still defaulting to 10-day courses 6, the evidence clearly supports shorter durations for most uncomplicated infections.

Treatment should extend 48-72 hours beyond clinical improvement rather than following arbitrary calendar-based durations 3. If patients are not improving with appropriate antibiotics, reassess the diagnosis rather than extending duration 1.

Populations Requiring Longer Courses

  • Children <2 years with AOM (insufficient evidence for short-course therapy) 7
  • Recent AOM within the preceding month 4
  • Complicated anatomy (e.g., bronchiectasis) 1
  • Recent history of resistant bacterial infections 1
  • Any confirmed S. pyogenes infection when using standard penicillin dosing 5, 3

Antimicrobial Stewardship Impact

Shorter courses reduce:

  • Antibiotic resistance (6.1 resistant infections per 10,000 person-days after antibiotic receipt) 1
  • Adverse events (up to 20% of patients experience side effects) 1
  • C. difficile infections 1
  • Overall antibiotic exposure and selection pressure 1

The default should be 5 days for uncomplicated infections in appropriate populations, with 10 days reserved for specific indications like S. pyogenes pharyngitis or high-risk scenarios.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.